Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
10.6M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
300
-
Shares change
-
-934
-
Total reported value, excl. options
-
$1K
-
Value change
-
-$6K
-
Number of sells
-
-1
-
Price
-
$3.33
Significant Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q4 2019
2 filings reported holding ARDS - Aridis Pharmaceuticals, Inc. - Common Stock as of Q4 2019.
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 300 shares
of 10.6M outstanding shares and own 0% of the company stock.
Largest 7 shareholders include WELLS FARGO & COMPANY/MN (300 shares), VICTORY CAPITAL MANAGEMENT INC (0 shares), VANGUARD GROUP INC (74.3K shares), MILLENNIUM MANAGEMENT LLC (11.4K shares), BlackRock Inc. (5.72K shares), UBS Group AG (734 shares), and MORGAN STANLEY (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.